Emerging antifungal resistance in Candida parapsilosis: the end of the innocence.

Guinea, J. Escribano, P. Cadeau, M. Lombardi, L. Morio, F.

https://doi.org/10.1038/s44259-025-00173-5

P284

Nat. Commun. 2024, 15, 9190.

Alternative sulphur metabolism in the fungal pathogen Candida parapsilosis.

Lombardi, L. Salzberg, L.I. Cinnéide, E.O. O'Brien, C. Morio, F. Turner, S.A. Byrne, K.P. Butler, G.

https://doi.org/10.1038/s41467-024-53442-8

P209

PLoS Pathog. 2020, 16, e1008201.

The CRISPR toolbox in medical mycology: State of the art and perspectives.

Morio, F. Lombardi, L. Butler, G.

doi: 10.1371/journal.ppat.1008201

P192

J. Antimicrob. Chemother. 2019, 74, 2230-2238.

Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.

Morio, F. Lombardi, L. Binder, U. Loge, C. Robert, E. Graessle, D. Bodin, M. Lass-Flörl, C. Butler, G. Le Pape, P.

doi: 10.1093/jac/dkz204